June 22 (Reuters) - The U.S. Food and Drug Administration has declined to approve Achieve Life Sciences' drug to treat nicotine dependence in adults, the company said on Monday. The company said the F ...
BioTech Social Inc. develops financing tools that expand access to capital for biotech, med-tech, pharma-tech, diagnostic, ...
Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a ...
In this week’s edition of InnovationRx, we look at breakthroughs from ASCO, Harrison.ai's U.S. expansion, Clear's move into ...
Buoyed by the rapid development of COVID-19 vaccines, the life sciences industry is on track for a succession of upheavals already transforming patient care, business models, and market dynamics. In ...
The Life Sciences Research Initiative will direct $80 million annually over the next two years to fuel breakthroughs and ...
As the Life Sciences Industry Awards marks its fourth year, a record 76 entries reflect the depth of talent and ambition ...
Nasus Pharma Ltd. (NYSE: NSRX) ('Nasus Pharma” or the 'Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced that the Company ...
Massachusetts built itself into a global biotech powerhouse over more than a decade of uninterrupted job growth. A new report ...
Explore the 2026 Life Sciences Visionaries by LA Times Studios. Meet the scientists, researchers, and executives driving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results